Medication use for epilepsy prevention after stroke

Reading time approx. 1 minute
This page contains 1 evidence gap
  1. Medication use for epilepsy prevention after stroke
Population:
Adults with a recent stroke
Intervention:
Pharmacological treatment for epilepsy prevention
Comparison:
No treatment or another active treatment than the intervention
Outcomes:
Clinically diagnosed epilepsy, epileptic seizures

What evidence is needed?

More primary research is needed.

What evidence is available?

Reliable systematic reviews that show evidence gaps:

Chang RS, Leung WC, Vassallo M, Sykes L, Battersby Wood E, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev. 2022;2(2):CD005398. More about the review

Reliable, but not updated, systematic reviews that show evidence gaps:

None identified

Information from SBU Enquiry Service: SBU. Läkemedelsbehandling för att förebygga epilepsi efter stroke eller traumatisk hjärnskada [Medication use for epilepsy prevention after stroke or traumatic brain injury]. Stockholm: Statens beredning för medicinsk och social utvärdering (SBU); 2024. SBU:s upplysningstjänst. More about the report

Registration number:
Published:
Research conducted after publication could potentially change the nature of the evidence.
To top

Evidence gap identifies methods or practices for which no conclusive systematic review of benefits and harms has been published. Gaps in scientific evidence appear on the SBU website to help researchers and granting agencies identify areas that are in need of research or systematic review. An additional objective is to offer healthcare and social service providers a basis for setting priorities.